In 2017, the prevalence of MDD was estimated to be 7.1% (about 17 million adults) in the United States ( Kryst et al., 2020 ), which has been an increasing trend in recent years.
← all excerpts
Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials.
1
—
—